Identification and quantification of Roseburia intestinalis and Escherichia coli in hypertensive patients in Denpasar

K. Pinatih, D. Wihandani, A. E. Darwinata, Gede Setula Narayana, I Putu Gede Septiawan Saputra, I Gede Putu Supadmanaba
{"title":"Identification and quantification of Roseburia intestinalis and Escherichia coli in hypertensive patients in Denpasar","authors":"K. Pinatih, D. Wihandani, A. E. Darwinata, Gede Setula Narayana, I Putu Gede Septiawan Saputra, I Gede Putu Supadmanaba","doi":"10.15562/ijbs.v17i1.457","DOIUrl":null,"url":null,"abstract":"Background: Low-grade chronic inflammation may contribute to the development of atherosclerosis as well as hypertension by inducing the production of pro-inflammatory cytokines. Several studies have revealed a relationship between the microbiota living in the gut and the incidence of hypertension. Two of several gut microbiota that contributed, in this case, are Escherichia coli (E. coli) and Roseburia intestinalis (R. intestinalis). Therefore this study aimed to identify and quantify gut microbes namely R. intestinalis and E.coli in hypertensive patients in Bali, especially in Denpasar City.\nMethods: This research is a cross-sectional study located at South Denpasar Health Center I, Bali, and the Integrated Biomedical Laboratory, Faculty of Medicine, Universitas Udayana. The sample in this study were hypertensive patients who had been registered at South Denpasar Health Center I and who met the inclusion criteria and did not meet the exclusion criteria. The E. coli and R. intestinalis concentrations were assessed by conducting DNA isolation and RT-qPCR. Statistical analysis using univariate analysis, bivariate analysis using the Independent T-Test; Mann-Whitney Test; Chi-Square, and ROC analysis\nResults: There were 70 subjects included in this study. Thirty-one subjects were hypertensive patients and the other 39 patients were not hypertensive. The age of the subjects between the two groups was found statistically significant (p=0.007). We also found that comorbid were found mostly in hypertensive patients (p=0.009). Most of the comorbid experienced among them were cardiovascular diseases and diabetes mellitus. Hypertensive subjects had more E. coli concentration in their gut compared with non-hypertensive subjects (p=0.048), while R. intestinalis concentrations were similar in both groups (p>0.05). From the multivariate analysis, it was found that hypertensive patients tended to have a higher concentration of E. coli than non-hypertensive patients (p=0.012; 95% CI:0.055–0.417).\nConclusion: E. coli concentration in the gut is independently associated with the incidence of hypertension, while R. intestinalis concentration is not.","PeriodicalId":55769,"journal":{"name":"Indonesia Journal of Biomedical Science","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesia Journal of Biomedical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15562/ijbs.v17i1.457","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Low-grade chronic inflammation may contribute to the development of atherosclerosis as well as hypertension by inducing the production of pro-inflammatory cytokines. Several studies have revealed a relationship between the microbiota living in the gut and the incidence of hypertension. Two of several gut microbiota that contributed, in this case, are Escherichia coli (E. coli) and Roseburia intestinalis (R. intestinalis). Therefore this study aimed to identify and quantify gut microbes namely R. intestinalis and E.coli in hypertensive patients in Bali, especially in Denpasar City. Methods: This research is a cross-sectional study located at South Denpasar Health Center I, Bali, and the Integrated Biomedical Laboratory, Faculty of Medicine, Universitas Udayana. The sample in this study were hypertensive patients who had been registered at South Denpasar Health Center I and who met the inclusion criteria and did not meet the exclusion criteria. The E. coli and R. intestinalis concentrations were assessed by conducting DNA isolation and RT-qPCR. Statistical analysis using univariate analysis, bivariate analysis using the Independent T-Test; Mann-Whitney Test; Chi-Square, and ROC analysis Results: There were 70 subjects included in this study. Thirty-one subjects were hypertensive patients and the other 39 patients were not hypertensive. The age of the subjects between the two groups was found statistically significant (p=0.007). We also found that comorbid were found mostly in hypertensive patients (p=0.009). Most of the comorbid experienced among them were cardiovascular diseases and diabetes mellitus. Hypertensive subjects had more E. coli concentration in their gut compared with non-hypertensive subjects (p=0.048), while R. intestinalis concentrations were similar in both groups (p>0.05). From the multivariate analysis, it was found that hypertensive patients tended to have a higher concentration of E. coli than non-hypertensive patients (p=0.012; 95% CI:0.055–0.417). Conclusion: E. coli concentration in the gut is independently associated with the incidence of hypertension, while R. intestinalis concentration is not.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
登巴萨地区高血压患者肠道玫瑰菌和大肠杆菌的鉴定与定量
背景:低级别慢性炎症可能通过诱导促炎细胞因子的产生而促进动脉粥样硬化和高血压的发展。一些研究已经揭示了生活在肠道中的微生物群与高血压发病率之间的关系。在这种情况下,肠道微生物群中的两种是大肠杆菌(E. coli)和肠道玫瑰菌(R. testinalis)。因此,本研究旨在鉴定和定量巴厘,特别是登巴萨市高血压患者肠道微生物,即肠球菌和大肠杆菌。方法:本研究是一项横断面研究,位于巴厘岛南登巴萨健康中心和乌达亚那大学医学院综合生物医学实验室。本研究的样本是在南登巴萨第一健康中心登记的高血压患者,符合纳入标准,不符合排除标准。采用DNA分离和RT-qPCR检测大肠杆菌和大肠杆菌浓度。统计分析采用单变量分析,双变量分析采用独立t检验;Mann-Whitney测试;结果:本研究共纳入70名受试者。31例为高血压患者,39例为非高血压患者。两组患者年龄差异有统计学意义(p=0.007)。我们还发现合并症主要见于高血压患者(p=0.009)。其中以心血管疾病和糖尿病居多。高血压组肠道内大肠杆菌浓度高于非高血压组(p=0.048),两组肠道内大肠杆菌浓度相近(p>0.05)。多因素分析发现,高血压患者的大肠杆菌浓度往往高于非高血压患者(p=0.012;95%置信区间:0.055—-0.417)。结论:肠道内大肠杆菌浓度与高血压发病率独立相关,肠内大肠杆菌浓度与高血压发病率独立相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊最新文献
Immune regulation in obesity: a narrative review Identification and quantification of Roseburia intestinalis and Escherichia coli in hypertensive patients in Denpasar Change of ABO blood group in a patient with Acute Myelocytic Leukemia (AML): a case report Cardiorenal Syndrome: revisiting its pathophysiology and classification The effectivity and safety of cisternostomy and decompressive craniectomy as management of brain trauma: a systematic review and meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1